Efficacy of low dose spironolactone in chronic kidney disease with resistant hypertension

To determine the antihypertensive benefit of adding low dose sprinolactone to multi-drug regimens that included a diuretic, a calcium channel blocker and angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with moderately severe chronic kidney disease (CKD) [glomerula...

Full description

Bibliographic Details
Main Authors: Rozita Abolghasmi, Omolbanin Taziki
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2011;volume=22;issue=1;spage=75;epage=78;aulast=Abolghasmi